Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Precipio Debt to Equity Ratio 2010-2024 | PRPO

Current and historical debt to equity ratio values for Precipio (PRPO) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Precipio debt/equity for the three months ending September 30, 2024 was 0.02.
  
Precipio Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.01B $0.01B 0.42
2024-06-30 $0.01B $0.01B 0.43
2024-03-31 $0.00B $0.01B 0.30
2023-12-31 $0.00B $0.01B 0.25
2023-09-30 $0.01B $0.01B 0.47
2023-06-30 $0.01B $0.01B 0.38
2023-03-31 $0.01B $0.01B 0.37
2022-12-31 $0.01B $0.02B 0.31
2022-09-30 $0.01B $0.02B 0.29
2022-06-30 $0.01B $0.02B 0.26
2022-03-31 $0.01B $0.02B 0.26
2021-12-31 $0.01B $0.03B 0.24
2021-09-30 $0.01B $0.03B 0.22
2021-06-30 $0.01B $0.03B 0.23
2021-03-31 $0.01B $0.02B 0.40
2020-12-31 $0.01B $0.01B 0.46
2020-09-30 $0.01B $0.01B 0.50
2020-06-30 $0.01B $0.01B 0.51
2020-03-31 $0.01B $0.01B 0.68
2019-12-31 $0.01B $0.01B 0.48
2019-09-30 $0.01B $0.02B 0.47
2019-06-30 $0.01B $0.01B 0.56
2019-03-31 $0.01B $0.01B 1.20
2018-12-31 $0.02B $0.01B 2.53
2018-09-30 $0.02B $0.01B 1.69
2018-06-30 $0.01B $0.01B 1.12
2018-03-31 $0.01B $0.01B 0.95
2017-12-31 $0.01B $0.01B 1.09
2017-09-30 $0.02B $0.02B 0.71
2017-06-30 $0.02B $0.02B 0.87
2017-03-31 $0.02B $-0.02B -1.06
2016-12-31 $0.01B $-0.01B -1.13
2016-09-30 $0.02B $-0.02B -1.12
2016-06-30 $0.02B $-0.02B -1.19
2016-03-31 $0.02B $-0.02B -1.23
2015-12-31 $0.02B $-0.01B -1.38
2015-09-30 $0.02B $0.01B 2.64
2015-06-30 $0.02B $0.01B 1.88
2015-03-31 $0.02B $0.01B 2.43
2014-12-31 $0.02B $0.01B 3.58
2014-09-30 $0.02B $0.01B 2.02
2014-06-30 $0.02B $0.01B 2.00
2014-03-31 $0.02B $0.01B 1.15
2013-12-31 $0.02B $0.01B 1.65
2013-09-30 $0.02B $0.02B 1.16
2013-06-30 $0.02B $0.02B 0.87
2013-03-31 $0.02B $0.02B 0.72
2012-12-31 $0.02B $0.02B 0.91
2012-09-30 $0.02B $0.02B 0.90
2012-06-30 $0.02B $0.03B 0.76
2012-03-31 $0.02B $0.03B 0.82
2011-12-31 $0.02B $0.01B 2.04
2011-09-30 $0.03B $-0.00B -20.92
2011-06-30 $0.03B $0.00B 275.58
2011-03-31 $0.03B $0.01B 4.62
2010-12-31 $0.02B $0.01B 2.77
2010-09-30 $0.01B $0.01B 0.50
2010-06-30 $0.00B $0.01B 0.45
2010-03-31 $0.01B $0.01B 0.45
2009-12-31 $0.00B $0.01B 0.37
2009-09-30 $0.00B $0.01B 0.34
2009-06-30 $0.00B $0.01B 0.35
2009-03-31 $0.01B $0.01B 0.37
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.008B $0.015B
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
Stock Name Country Market Cap PE Ratio
Inspire Medical Systems (INSP) United States $5.669B 176.81
Hims & Hers Health (HIMS) United States $5.506B 140.00
Tempus AI (TEM) United States $5.393B 0.00
IRhythm Technologies (IRTC) United States $2.799B 0.00
Enovis (ENOV) United States $2.475B 16.78
Privia Health (PRVA) United States $2.357B 196.40
Azenta (AZTA) United States $2.286B 122.05
Omnicell (OMCL) United States $2.053B 67.15
10x Genomics (TXG) United States $1.718B 0.00
Clover Health Investments (CLOV) United States $1.568B 0.00
Schrodinger (SDGR) United States $1.486B 0.00
Phreesia (PHR) United States $1.464B 0.00
Butterfly Network (BFLY) United States $0.846B 0.00
Standard BioTools (LAB) United States $0.651B 0.00
Fulgent Genetics (FLGT) United States $0.563B 0.00
Talkspace (TALK) United States $0.529B 0.00
Definitive Healthcare (DH) United States $0.476B 82.40
Health Catalyst (HCAT) United States $0.446B 0.00
TruBridge (TBRG) United States $0.297B 86.52
Pulmonx (LUNG) United States $0.257B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
EUDA Health Holdings (EUDA) Singapore $0.114B 0.00
American Well (AMWL) United States $0.108B 0.00
P3 Health Partners (PIII) United States $0.090B 0.00
HeartBeam (BEAT) United States $0.063B 0.00
CareCloud (CCLD) United States $0.062B 0.00
Outset Medical (OM) United States $0.061B 0.00
111 (YI) China $0.054B 0.00
Zepp Health (ZEPP) China $0.043B 0.00
Zhongchao (ZCMD) China $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.041B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.018B 0.00
MSP Recovery (MSPR) United States $0.016B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Predictive Oncology (POAI) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00